Emergence of Hepatitis C Virus Genotype Recombinant Forms 2k/1b in Georgia

被引:3
|
作者
Zakalashvili, Mamuka [1 ]
Weizenegger, Michael [2 ]
Bartel, Jan [2 ]
Markowski, Monika [2 ]
Zarkua, Jaba [1 ]
Kavsadze, Salome [1 ]
Kvatadze, Ketevan [1 ]
Basheleishvili, George [1 ]
Phirtskhalaishvili, Tamar [1 ]
Dzagania, Tamar [1 ]
Zangurashvili, Lela [1 ]
Kankia, Nino [1 ]
Jashiashvili, Nino [1 ]
Lomidze, Maka [1 ]
Telia, Tengiz [1 ]
Kerashvili, Vakhtang [1 ]
Zhamutashvili, Maia [1 ]
Abramishvili, Nikoloz [1 ]
Rtskhiladze, Irakli [1 ]
Metreveli, David [1 ]
机构
[1] Med Ctr Mrcheveli, 9 Al Kazbegi Ave, Tbilisi 0160, Georgia
[2] Dr Limbach & Kollegen, Med Versorgungszentrum, Heidelberg, Germany
关键词
hepatitis C virus; genotype; recombinant form; sequencing; INTERGENOTYPIC RECOMBINANT; MOLECULAR EPIDEMIOLOGY; STRAINS;
D O I
10.7754/Clin.Lab.2016.151210
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Hepatitis C virus (HCV) evolution is thought to proceed by mutations within the six major genotypes. Studies of HCV recombinant genotypes in different parts of the world have recently been initiated. Only a few cases of recombination have been identified worldwide, predominantly in Eastern Europe and Asia. In 2011 we detected the recombinant form (RF) of a HCV genotype RF_ 2k/1b in Georgia. Therefore, we reviewed HCV genotyping data of 491 patients with chronic hepatitis C virus infections of our center in Tbilisi over a period of two years. Methods: Initially all genotyping analyses were performed with the VERSANT HCV genotype assay (Siemens, LiPA). In a second analysis, parts of the core and the NS5B region were sequenced for all HCV genotypes 2a/2c. Results: Approximately 2/3 of genotype 2 cases were identified as the recombinant form HCV-RF 2k/1b. Overall, this type represented 19% of all HCV patients who underwent genotyping. Conclusions: We can conclude that almost 20% of HCV infected Georgian patients are infected with HCVRF_2k/1b.
引用
收藏
页码:1347 / 1351
页数:5
相关论文
共 50 条
  • [1] EMERGENCE OF HEPATITIS C VIRUS GENOTYPE RECOMBINANT FORMS 2K/1B IN GEORGIA
    Zakalashvili, M.
    Weizenegger, M.
    Kavsadze, S.
    Kvatadze, K.
    Basheleishvili, G.
    Phirtskhalaishvili, T.
    Dzagania, T.
    Zarqua, J.
    Zangurashvili, L.
    Kankia, N.
    Jashiashvili, N.
    Lomidze, M.
    Kerashvili, V.
    Zhamutashvili, M.
    Abramishvili, N.
    Metr, D.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S688 - S689
  • [2] High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment
    Karchava, Marine
    Waldenstrom, Jesper
    Parker, Monica
    Hallack, Renee
    Sharvadze, Lali
    Gatserelia, Lana
    Chkhartishvili, Nikoloz
    Dvali, Natia
    Dzigua, Lela
    Dolmazashvili, Ekaterine
    Norder, Helene
    Tsertsvadze, Tengiz
    HEPATOLOGY RESEARCH, 2015, 45 (13) : 1292 - 1298
  • [3] Hepatitis C virus genotype 1 and 2 recombinant genomes and the phylogeographic history of the 2k/1b lineage
    Hostager, Reilly
    Ragonnet-Cronin, Manon
    Murrell, Ben
    Hedskog, Charlotte
    Osinusi, Anu
    Susser, Simone
    Sarrazin, Christoph
    Svarovskaia, Evguenia
    Wertheim, Joel O.
    VIRUS EVOLUTION, 2019, 5 (02)
  • [4] Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia
    Zakalashvili, Mamuka
    Zarkua, Jaba
    Weizenegger, Michael
    Bartel, Jan
    Raabe, Monika
    Zangurashvili, Lela
    Kankia, Nino
    Jashiashvili, Nino
    Lomidze, Maka
    Telia, Tengiz
    Kerashvili, Vakhtang
    Zhamutashvili, Maia
    Abramishvili, Nikoloz
    Hedskog, Charlotte
    Chodavarapu, Krishna
    Brainard, Diana M.
    McHutchison, John G.
    Mo, Hongmei
    Svarovskaia, Evguenia
    Gish, Robert G.
    Rtskhiladze, Irakli
    Metreveli, David
    LIVER INTERNATIONAL, 2018, 38 (03) : 451 - 457
  • [5] Treatment outcomes of hepatitis C virus recombinant form 2k/1b with sofosbuvir based regimens in Georgia
    Zakalashvili, M.
    Zarkua, J.
    Weizenegger, M.
    Bartel, J.
    Raabe, M.
    Telia, T.
    Zhamutashvili, M.
    Metreveli, S.
    Barnova, M.
    Abramishvili, N.
    Gish, R.
    Rtskhiladze, I.
    Metreveli, D.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S302 - S303
  • [6] Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras
    Susser, Simone
    Dietz, Julia
    Schlevogt, Bernhard
    Zuckerman, Eli
    Barak, Mira
    Piazzolla, Valeria
    Howe, Anita
    Hinrichsen, Holger
    Passmann, Sandra
    Daniel, Rasha
    Cornberg, Markus
    Mangia, Alessandra
    Zeuzem, Stefan
    Sarrazin, Christoph
    JOURNAL OF HEPATOLOGY, 2017, 67 (04) : 680 - 686
  • [7] Assessment of treatment options for patients with hepatitis C virus recombinant form 2k/1b
    Zakalashvili, Mamuka
    Zarkua, Jaba
    Gish, Robert G.
    Zhamutashvili, Maia
    Sartania, Vakhtang
    Weizenegger, Michael
    Bartel, Jan
    Raabe, Monika
    Gvinjilia, Lia
    Metreveli, Sophia
    Barnova, Maka
    Abramishvili, Nikoloz
    Rtskhiladze, Irakli
    Metreveli, David
    HEPATOLOGY RESEARCH, 2021, 51 (02) : 156 - 165
  • [8] Origin and Evolution of the Unique Hepatitis C Virus Circulating Recombinant Form 2k/1b
    Raghwani, Jayna
    Thomas, Xiomara V.
    Koekkoek, Sylvie M.
    Schinkel, Janke
    Molenkamp, Richard
    van de Laar, Thijs J.
    Takebe, Yutaka
    Tanaka, Yasuhito
    Mizokami, Masashi
    Rambaut, Andrew
    Pybus, Oliver G.
    JOURNAL OF VIROLOGY, 2012, 86 (04) : 2212 - 2220
  • [9] Diagnosis of hepatitis C virus genotype 2k/1b needs NS5B sequencing
    De Keukeleire, Steven
    Descheemaeker, Patrick
    Reynders, Marijke
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 41 : 1 - 2
  • [10] Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form
    Schuermans, Wim
    Orlent, Hans
    Desombere, Isabelle
    Descheemaeker, Patrick
    Van Vlierberghe, Hans
    Geerts, Anja
    Verhelst, Xavier
    Reynders, Marijke
    Padalko, Elizaveta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (09):